South Florida Institute for Reproductive Medicine/IVFMD, located in Hollywood, underwent a Food and Drug Administration (FDA) inspection on March 20 focused on human cellular, tissue, and gene therapies, according to data posted on the FDA’s website.
The FDA’s final report noted there was no need for the organization to make any corrections regarding its management operations.
The agency regularly conducts inspections nationwide to confirm that facilities and products meet all laws and regulations under its jurisdiction to help ensure public health. The findings from these inspections are then made accessible to the public.
The agency’s website states that the FDA oversees safety and quality for human and animal drugs, biological products, medical devices, and tobacco products.
Information in this article was obtained from the U.S. Food and Drug Administration. The source data can be found here.
